Sarah Elizabeth Turbett, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anaplasma phagocytophilum | 3 | 2022 | 37 | 2.170 |
Why?
|
Enterobacteriaceae | 5 | 2023 | 172 | 1.540 |
Why?
|
Anaplasmosis | 2 | 2022 | 37 | 1.480 |
Why?
|
Exanthema | 5 | 2024 | 504 | 1.280 |
Why?
|
Syphilis | 2 | 2024 | 240 | 1.220 |
Why?
|
Borrelia | 2 | 2023 | 66 | 1.080 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 980 | 1.030 |
Why?
|
Feces | 5 | 2024 | 1466 | 0.910 |
Why?
|
Hafnia | 1 | 2023 | 3 | 0.890 |
Why?
|
Lyme Disease | 3 | 2024 | 630 | 0.870 |
Why?
|
Borrelia burgdorferi | 2 | 2024 | 182 | 0.820 |
Why?
|
Enterobacteriaceae Infections | 3 | 2023 | 192 | 0.810 |
Why?
|
Arthritis | 2 | 2024 | 666 | 0.740 |
Why?
|
Sin Nombre virus | 1 | 2020 | 3 | 0.720 |
Why?
|
Hantavirus Pulmonary Syndrome | 1 | 2020 | 11 | 0.720 |
Why?
|
Antibodies, Viral | 7 | 2022 | 3145 | 0.710 |
Why?
|
Ehrlichiosis | 1 | 2020 | 28 | 0.700 |
Why?
|
Coccidioidomycosis | 1 | 2020 | 37 | 0.690 |
Why?
|
Drug Resistance, Bacterial | 4 | 2023 | 1054 | 0.690 |
Why?
|
Specimen Handling | 2 | 2024 | 708 | 0.680 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 193 | 0.680 |
Why?
|
Bites and Stings | 1 | 2020 | 93 | 0.660 |
Why?
|
Lung Diseases, Fungal | 1 | 2020 | 125 | 0.650 |
Why?
|
Pancytopenia | 1 | 2020 | 101 | 0.650 |
Why?
|
Organ Transplantation | 3 | 2023 | 1150 | 0.630 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 251 | 0.610 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 49 | 0.610 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 96 | 0.600 |
Why?
|
Glomerulonephritis | 1 | 2020 | 337 | 0.600 |
Why?
|
Tenosynovitis | 1 | 2017 | 57 | 0.580 |
Why?
|
Leptospirosis | 1 | 2017 | 31 | 0.570 |
Why?
|
Antifungal Agents | 1 | 2022 | 745 | 0.560 |
Why?
|
Aortitis | 2 | 2014 | 74 | 0.550 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 224 | 0.540 |
Why?
|
Diagnosis, Differential | 10 | 2024 | 12968 | 0.530 |
Why?
|
Fever | 6 | 2022 | 1618 | 0.510 |
Why?
|
Neisseria gonorrhoeae | 1 | 2017 | 237 | 0.490 |
Why?
|
Communicable Diseases | 1 | 2023 | 879 | 0.490 |
Why?
|
Lung | 5 | 2022 | 9988 | 0.460 |
Why?
|
beta-Lactamases | 6 | 2023 | 304 | 0.460 |
Why?
|
Arthritis, Infectious | 1 | 2017 | 345 | 0.450 |
Why?
|
Serologic Tests | 3 | 2024 | 383 | 0.440 |
Why?
|
Gonorrhea | 1 | 2017 | 342 | 0.440 |
Why?
|
Endocarditis, Bacterial | 2 | 2014 | 445 | 0.430 |
Why?
|
Klebsiella Infections | 2 | 2024 | 147 | 0.420 |
Why?
|
Sepsis | 2 | 2024 | 2594 | 0.410 |
Why?
|
Dyspnea | 1 | 2020 | 1352 | 0.400 |
Why?
|
Immunoglobulin M | 4 | 2024 | 1529 | 0.390 |
Why?
|
Colistin | 2 | 2023 | 45 | 0.380 |
Why?
|
Travel | 4 | 2023 | 786 | 0.370 |
Why?
|
Aorta | 2 | 2014 | 2042 | 0.330 |
Why?
|
Antibodies, Bacterial | 3 | 2024 | 1470 | 0.330 |
Why?
|
Staphylococcal Infections | 2 | 2014 | 1405 | 0.310 |
Why?
|
Decision Making | 1 | 2022 | 3924 | 0.300 |
Why?
|
Aortic Valve | 2 | 2014 | 1998 | 0.280 |
Why?
|
Cough | 2 | 2022 | 595 | 0.280 |
Why?
|
Myocardium | 1 | 2020 | 4687 | 0.280 |
Why?
|
Lymph Nodes | 1 | 2018 | 3491 | 0.280 |
Why?
|
Humans | 52 | 2024 | 760276 | 0.260 |
Why?
|
Klebsiella pneumoniae | 2 | 2024 | 255 | 0.250 |
Why?
|
Pneumonia | 3 | 2022 | 2138 | 0.240 |
Why?
|
Bacteremia | 2 | 2024 | 979 | 0.240 |
Why?
|
Diarrhea | 2 | 2022 | 1341 | 0.240 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4546 | 0.240 |
Why?
|
Serotyping | 1 | 2024 | 324 | 0.230 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1933 | 0.220 |
Why?
|
Skin | 2 | 2014 | 4467 | 0.220 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2024 | 43 | 0.220 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.220 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 238 | 0.210 |
Why?
|
O Antigens | 1 | 2024 | 196 | 0.210 |
Why?
|
Sensitivity and Specificity | 6 | 2024 | 14655 | 0.210 |
Why?
|
Bedding and Linens | 1 | 2023 | 41 | 0.210 |
Why?
|
Radiography, Thoracic | 2 | 2020 | 1295 | 0.200 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 167 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7809 | 0.190 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7398 | 0.190 |
Why?
|
Peromyscus | 1 | 2020 | 16 | 0.180 |
Why?
|
Fatal Outcome | 3 | 2020 | 1833 | 0.180 |
Why?
|
Transplants | 1 | 2022 | 206 | 0.170 |
Why?
|
Bone Marrow Examination | 1 | 2020 | 155 | 0.170 |
Why?
|
Patient Isolation | 1 | 2020 | 100 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 3806 | 0.170 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 617 | 0.160 |
Why?
|
Malacoplakia | 1 | 2019 | 14 | 0.160 |
Why?
|
Escherichia coli | 2 | 2023 | 4223 | 0.160 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1951 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 238 | 0.160 |
Why?
|
Carbapenems | 1 | 2020 | 123 | 0.160 |
Why?
|
Blood Cell Count | 1 | 2020 | 398 | 0.160 |
Why?
|
Chills | 1 | 2018 | 17 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.160 |
Why?
|
Leukocytosis | 1 | 2020 | 251 | 0.160 |
Why?
|
Lung Transplantation | 2 | 2019 | 1304 | 0.160 |
Why?
|
Culture Media | 1 | 2020 | 899 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 362 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 364 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 418 | 0.150 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 220 | 0.150 |
Why?
|
Infectious Disease Incubation Period | 1 | 2017 | 16 | 0.150 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1155 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 750 | 0.150 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1936 | 0.150 |
Why?
|
Indonesia | 1 | 2017 | 128 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 612 | 0.140 |
Why?
|
Tretinoin | 1 | 2020 | 520 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 658 | 0.140 |
Why?
|
Thorax | 1 | 2020 | 553 | 0.140 |
Why?
|
Candida | 1 | 2017 | 172 | 0.140 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 37 | 0.140 |
Why?
|
Disease Outbreaks | 2 | 2023 | 1759 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2020 | 1600 | 0.130 |
Why?
|
Synovial Fluid | 1 | 2017 | 395 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Algorithms | 4 | 2024 | 13959 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 364 | 0.120 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 133 | 0.120 |
Why?
|
Cross Infection | 1 | 2024 | 1434 | 0.120 |
Why?
|
Middle Aged | 12 | 2024 | 220179 | 0.120 |
Why?
|
Thrombocytopenia | 2 | 2020 | 1174 | 0.120 |
Why?
|
Ankle | 1 | 2017 | 350 | 0.120 |
Why?
|
Bronchoscopy | 1 | 2020 | 908 | 0.120 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 238 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1180 | 0.110 |
Why?
|
Abdomen | 1 | 2020 | 1125 | 0.110 |
Why?
|
Temperature | 1 | 2020 | 2221 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2019 | 857 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 219 | 0.110 |
Why?
|
Edema | 1 | 2017 | 772 | 0.110 |
Why?
|
Phylogeny | 1 | 2020 | 2775 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2721 | 0.110 |
Why?
|
Uveitis | 1 | 2016 | 393 | 0.100 |
Why?
|
Male | 14 | 2024 | 359427 | 0.100 |
Why?
|
Hand | 1 | 2017 | 903 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20483 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1228 | 0.090 |
Why?
|
New England | 2 | 2024 | 1045 | 0.090 |
Why?
|
Headache | 1 | 2017 | 1249 | 0.080 |
Why?
|
Tissue and Organ Procurement | 1 | 2017 | 944 | 0.080 |
Why?
|
Cross Reactions | 2 | 2022 | 818 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1084 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 780 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 80311 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
Genotype | 1 | 2022 | 12959 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6775 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5422 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 5960 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3217 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15272 | 0.060 |
Why?
|
Monkeypox virus | 1 | 2023 | 42 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20045 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Female | 9 | 2024 | 391024 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5066 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 157 | 0.050 |
Why?
|
Young Adult | 2 | 2020 | 58673 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 561 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 328 | 0.050 |
Why?
|
Immunoassay | 1 | 2024 | 748 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 393 | 0.050 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 858 | 0.040 |
Why?
|
Metagenomics | 1 | 2024 | 457 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 787 | 0.040 |
Why?
|
Metagenome | 1 | 2023 | 450 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4492 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 653 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17159 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54265 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40141 | 0.040 |
Why?
|
North America | 1 | 2022 | 1282 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2019 | 142 | 0.040 |
Why?
|
United States | 5 | 2024 | 72369 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 330 | 0.040 |
Why?
|
Animals | 2 | 2020 | 167935 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9283 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2022 | 3822 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3930 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1979 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2020 | 978 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13629 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1523 | 0.030 |
Why?
|
Syndrome | 1 | 2023 | 3278 | 0.030 |
Why?
|
Adult | 4 | 2024 | 219843 | 0.030 |
Why?
|
JC Virus | 1 | 2016 | 87 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11836 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2506 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58953 | 0.030 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 844 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2022 | 1884 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81212 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3106 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8621 | 0.020 |
Why?
|
Confusion | 1 | 2014 | 277 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5429 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3618 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2196 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2753 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8805 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5422 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2569 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7236 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9336 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1401 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2655 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3310 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2014 | 820 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5790 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 29951 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1108 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1894 | 0.020 |
Why?
|
Aged | 4 | 2020 | 169002 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74278 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1462 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15684 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8487 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4355 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25927 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36032 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10761 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7071 | 0.010 |
Why?
|
HIV-1 | 1 | 2016 | 6850 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41316 | 0.010 |
Why?
|